Hennion & Walsh Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.75M	Sell	47,113 -412	-0.9%	-$13.3K	0.05%	418
2026 Q1	$1.51M	Buy	47,525 +560	+1%	+$15.3K	0.05%	414
2025 Q4	$1.28M	Buy	46,965 +11,182	+31%	+$295K	0.04%	462
2025 Q3	$926K	Buy	35,783 +14,729	+70%	+$341K	0.03%	527
2025 Q2	$428K	Buy	+21,054	New	+$410K	0.02%	720

Other funds holding CLDX

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $816M AUM 42.46% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return